Metoprolol Succinate
Product Images NDC 50816-200

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 50816-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New American Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01

Image01
Metoprolol Succinate 25 mg extended-release tablets label showing 100 tablets per bottle. The product is manufactured by AstraZeneca AB in Sweden and labeled for New American Therapeutics in Parsippany, NJ. The label includes dosage strength, formulation, storage instructions, and barcode.*
FDA Label Image

Image02

Image02
Metoprolol Succinate 25 mg extended-release tablets label, showing 1000 tablets. Manufactured by AstraZeneca AB, Sweden, and labeled for New American Therapeutics, Parsippany, NJ. Product of Sweden. The label includes storage temperature and dosing information references, with the New American Therapeutics logo.*
FDA Label Image

Image03

Image03
Metoprolol Succinate 50 mg extended-release tablets label by New American Therapeutics. The label includes the dosage strength, tablet count of 100, manufacturer AstraZeneca AB in Sweden, and distributor New American Therapeutics in Parsippany, NJ. Dosage and storage warnings are present, including temperature range instructions and child protection advice.*
FDA Label Image

Image04

Image04
Metoprolol Succinate 50 mg extended-release tablets packaging label showing 1000 tablets. Manufactured by AstraZeneca AB, Sweden, and labeled by New American Therapeutics, Parsippany, NJ. The label indicates the product is a bulk package not intended for dispensing and storage instructions specifying temperature 15-30°C (59-86°F).*
FDA Label Image

Image05

Image05
Metoprolol Succinate extended-release tablets label showing 100 mg strength with a count of 100 tablets. The product is Rx only, manufactured by AstraZeneca AB in Sweden and marketed by New American Therapeutics in Parsippany, NJ. The label includes dosage storage instructions and batch information.*
FDA Label Image

Image06

Image06
Metoprolol Succinate extended-release tablets, 100 mg strength. The label indicates a bulk package of 1000 tablets. Manufactured by AstraZeneca AB in Sweden for New American Therapeutics, Parsippany, NJ. The product is prescription only and is a product of Sweden. Storage instructions and additional dosage information are provided in the package insert.*
FDA Label Image

Image07

Image07
METOPROLOL SUCCINATE 200 mg Extended-release Tablets packaging label showing 100 tablets. The label indicates Rx only, manufactured by New American Therapeutics under AstraZeneca AB in Sweden. Storage instructions and product origin are also included on the label.*
FDA Label Image

Image08

Image08
METOPROLOL SUCCINATE extended-release tablets 200 mg, 1000 count bottle labeled by New American Therapeutics. The product is manufactured by AstraZeneca AB, Sweden, and is intended Rx only. The label includes storage instructions and indicates the packaging is for dispensing, not for sale.*
FDA Label Image

Image09

Image09
A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event). Subgroups include geographic location, NYHA class, ejection fraction, etiology, sex, race, medical history, diabetes, hypertension, and heart rate. The plot compares metoprolol succinate extended-release tablets against placebo, indicating which group is favored for each outcome.*
FDA Label Image

Image10

Image10
Chemical structure of metoprolol succinate showing the molecular arrangement of the metoprolol moiety and succinate component as represented by the structural formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.